Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1073251 | 0.97 | — | — | |
| SCHEMBL1073252 | 0.97 | — | — | |
| SCHEMBL2071443 | 0.95 | TP53 (0.35) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL3041349 | 0.73 | CA2 (0.32) | — | |
| SCHEMBL28148643 | 0.72 | TP53 (0.36) | TP53SLC7A5 | |
| SCHEMBL11932153 | 0.72 | — | — | |
| SCHEMBL27484821 | 0.72 | TP53 (0.36) | TP53SLC7A5 | |
| SCHEMBL6799422 | 0.72 | — | — | |
| SCHEMBL23044830 | 0.70 | TP53 (0.35) | TP53 | |
| SCHEMBL21365304 | 0.70 | TP53 (0.35) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | claimed |
| US-11905315-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2024-02-20 | — | — | US | claimed |
| US-20210179672-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | GENISYS CREDIT UNION | 2021-06-17 | — | — | US | claimed |
| EP-2533633-B1 | FUNGICIDAL MIXTURES | LANXESS DISTRIB GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| WO-2016044655-A2 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC. (US) | 2016-03-24 | — | — | WO | claimed |
| US-20130195997-A1 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| EP-2460408-A1 | Nematicidal compositions | deVGen N.V. (BE) | 2012-06-06 | — | — | EP | claimed |
| US-20110319435-A1 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-12-29 | — | — | US | claimed |
| US-20240228396-A9 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228395-A9 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228394-A9 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-07-11 | — | — | US | disclosed |
| US-12031164-B2 | Fusion proteins, recombinant bacteria, and exosporium fragments for plant health | SPOGEN BIOTECH INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | disclosed |
| US-20240132417-A1 | METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES | SPOGEN BIOTECH INC (US) | 2024-04-25 | — | — | US | disclosed |
| US-6103726-A | FUNGICIDES; BACTERICIDES, INSECTICIDES; NEMATOCIDES; LARVACIDES; MITICIDES; CROPS, ESPECIALLY CEREALS AND RICE; LIVESTOCK | BAYER AKTIENGESELLSCHAFT (DE) | 2000-08-15 | — | — | US | disclosed |
| US-6100281-A | MICROBIOCIDES FOR CROP PROTECTION AND PRESERVATION OF ORGANIC MATERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-08-08 | — | — | US | disclosed |
| US-6090831-A | FUNGICIDE; BACTERICIDE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-07-18 | — | — | US | disclosed |
| US-6054473-A | 1,3-dimethyl-5-fluoro-pyrazole-4-carboxamide derivatives, their preparation and their use as microbicides | BAYER AKTIENGESELLSCHAFT (DE) | 2000-04-25 | — | — | US | disclosed |
| US-6043377-A | MICROBICIDES USEFUL IN CROP PROTECTION AND IN THE PROTECTION OF MATERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-03-28 | — | — | US | disclosed |
| US-5942528-A | INSECTICIDES, ARACHNICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12031164-B2 | Fusion proteins, recombinant bacteria, and exosporium fragments for plant health | ENGASE, LCT, CPB1 | TP53 3737/4885SLC7A5 3452/4885SLC1A3 3780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.